Douglas Corley to Time Factors
This is a "connection" page, showing publications Douglas Corley has written about Time Factors.
Connection Strength
1.965
-
Rising Early-onset Colorectal Cancer Incidence Is Not an Artifact of Increased Screening Colonoscopy Use in a Large, Diverse Healthcare System. Gastroenterology. 2022 01; 162(1):325-327.e3.
Score: 0.154
-
Promises and Potential Pitfalls of Shared Decision Making in Cancer Screening. Gastroenterology. 2020 03; 158(4):802-805.
Score: 0.136
-
Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5.
Score: 0.135
-
Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. Gastroenterology. 2019 01; 156(1):63-74.e6.
Score: 0.126
-
Primary care visit use after positive fecal immunochemical test for colorectal cancer screening. Cancer. 2017 Oct 01; 123(19):3744-3753.
Score: 0.115
-
Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017 Apr 25; 317(16):1631-1641.
Score: 0.114
-
Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency. Gastroenterology. 2017 03; 152(4):821-829.e1.
Score: 0.111
-
Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors. Aliment Pharmacol Ther. 2016 Jan; 43(1):73-82.
Score: 0.103
-
Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus. Dig Dis Sci. 2016 Jan; 61(1):70-9.
Score: 0.102
-
Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus. Dig Dis Sci. 2015 Feb; 60(2):436-43.
Score: 0.095
-
Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology. 2012 Apr; 142(4):744-53.
Score: 0.079
-
Can we improve adenoma detection rates? A systematic review of intervention studies. Gastrointest Endosc. 2011 Sep; 74(3):656-65.
Score: 0.076
-
Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci. 2009 Sep; 54(9):2031-9.
Score: 0.064
-
Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8.
Score: 0.063
-
Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway? Gastrointest Endosc. 2008 Mar; 67(3):399-401.
Score: 0.060
-
Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps. Gastroenterology. 2020 08; 159(2):502-511.e2.
Score: 0.035
-
Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019 Oct 02; 367:l5515.
Score: 0.034
-
Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019 Dec; 30(12):2515-2520.
Score: 0.034
-
World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer. Gastroenterology. 2018 09; 155(3):909-925.e3.
Score: 0.031
-
Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):158-164.
Score: 0.030
-
Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol. 2016 10; 14(10):1445-1451.e8.
Score: 0.027
-
Persistence with weekly alendronate therapy among postmenopausal women. Osteoporos Int. 2006; 17(6):922-8.
Score: 0.026
-
Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50.
Score: 0.026
-
The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection. Clin Infect Dis. 2005 Nov 01; 41(9):1335-40.
Score: 0.026
-
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015 Jul 01; 121(13):2281-5.
Score: 0.025
-
Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. Gastroenterology. 2015 Jun; 148(7):1353-61.e3.
Score: 0.025
-
Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015 Mar; 25(3):208-213.e1.
Score: 0.024
-
The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol. 2012 Jun; 36(3):306-16.
Score: 0.020
-
Does increased experience with laparoscopic cholecystectomy yield more complex bile duct injuries? Am J Surg. 2012 Apr; 203(4):480-7.
Score: 0.020
-
Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology. 2012 Mar; 142(3):442-452.e5; quiz e22-3.
Score: 0.020
-
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010 Sep 08; 102(17):1344-53.
Score: 0.018
-
New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1366-72; quiz 1301.
Score: 0.014